Folgen
Kenneth H. Eckels
Kenneth H. Eckels
Walter Reed Army Institute of Research
Bestätigte E-Mail-Adresse bei mail.mil
Titel
Zitiert von
Zitiert von
Jahr
Vaccine protection against Zika virus from Brazil
RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ...
Nature 536 (7617), 474-478, 2016
5912016
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ...
Science 353 (6304), 1129-1132, 2016
5492016
Rapid development of a DNA vaccine for Zika virus
KA Dowd, SY Ko, KM Morabito, ES Yang, RS Pelc, CR DeMaso, ...
Science 354 (6309), 237-240, 2016
4122016
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine
R Edelman, SS Wasserman, SA Bodison, RJ Putnak, KH Eckels, D Tang, ...
American Journal of Tropical Medicine and Hygiene 69 (6), 48, 2003
2472003
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak, BA Coller, G Voss, DW Vaughn, D Clements, I Peters, ...
Vaccine 23 (35), 4442-4452, 2005
2182005
Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.
BM Kaufman, PL Summers, DR Dubois, KH Eckels
The American journal of tropical medicine and hygiene 36 (2), 427-434, 1987
2111987
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo …
K Modjarrad, L Lin, SL George, KE Stephenson, KH Eckels, ...
The Lancet 391 (10120), 563-571, 2018
2002018
Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys
R Putnak, DA Barvir, JM Burrous, DR Dubois, VM D'Andrea, CH Hoke, ...
Journal of Infectious Diseases 174 (6), 1176-1184, 1996
1951996
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection
BM Kaufman, PL Summers, DR Dubois, WH Cohen, MK Gentry, ...
Am J Trop Med Hyg 41 (5), 576-580, 1989
1941989
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates
W Sun, R Edelman, N Kanesa-Thasan, KH Eckels, JR Putnak, AD King, ...
American Journal of Tropical Medicine and Hygiene 69 (6), 24-31, 2003
1932003
Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes
T Hase, PL Summers, KH Eckels
Archives of virology 104, 129-143, 1989
1741989
Production and evaluation of a formalin-killed Chikungunya vaccine
VR Harrison, KH Eckels, PJ Bartelloni, C Hampton
The Journal of Immunology 107 (3), 643-647, 1971
1661971
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
W Sun, D Cunningham, SS Wasserman, J Perry, JR Putnak, KH Eckels, ...
Human vaccines 5 (1), 33-40, 2009
1652009
Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus …
M Bray, BT Zhao, L Markoff, KH Eckels, RM Chanock, CJ Lai
Journal of Virology 63 (6), 2853-2856, 1989
1491989
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis
YM Zhang, EP Hayes, TC McCarty, DR Dubois, PL Summers, KH Eckels, ...
Journal of virology 62 (8), 3027-3031, 1988
1461988
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
S Simasathien, SJ Thomas, V Watanaveeradej, A Nisalak, C Barberousse, ...
American Journal of Tropical Medicine and Hygiene 78 (3), 426-433, 2008
1442008
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development
KH Eckels, WE Brandt, VR Harrison, JM McCown, PK Russell
Infection and immunity 14 (5), 1221-1227, 1976
1381976
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
VJ Gunther, R Putnak, KH Eckels, MP Mammen, JM Scherer, A Lyons, ...
Vaccine 29 (22), 3895-3904, 2011
1322011
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells
AK Srivastava, JR Putnak, SH Lee, SP Hong, SB Moon, DA Barvir, B Zhao, ...
Vaccine 19 (31), 4557-4565, 2001
1312001
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
P Abbink, RA Larocca, K Visitsunthorn, M Boyd, RA De La Barrera, ...
Science translational medicine 9 (420), eaao4163, 2017
1232017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20